Yes, RajaniMD Multi Collagen Peptides Powder is designed to support all skin types. Because it works from within, it helps support overall skin health rather than acting like a topical product.

If you have sensitive skin or specific health concerns, we recommend consulting your physician or reaching out to our team for personalized guidance.

Yes, AHA Firming Cream can be used on the body to support smoother, firmer-looking skin.

Yes. Ultra Moisture pairs well with AHA Firming Cream and helps support skin recovery, hydration, and barrier function. Together, they promote collagen support, improved glow, and a more refined finish.

AHA and retinol are best used on alternate nights to minimize irritation. Most people rotate—using retinol one night and AHA the next. If your skin is more sensitive, use each 1–2 times per week. Always apply SPF daily, especially when using exfoliating or retinol-based products.

Some individuals with rosacea tolerate AHA well, but results can vary. Because rosacea-prone skin is more sensitive, we recommend consulting your physician before use and starting slowly to assess tolerance.

You can start by using AHA Firming Cream 1–2 times per week in the evening, on nights you are not using Anteage. If layering, apply Anteage first, wait about 5 minutes, then apply the AHA. Adjust frequency based on your skin’s tolerance.

AHA Firming Cream is not recommended for the under-eye area. The skin here is thinner and more delicate, making it more prone to irritation from exfoliating acids.

For concerns like fine lines, crepey texture, and dark circles, we recommend using products specifically formulated for the eye area, such as the DEJ Eye Cream. Devices like the PlasmaGLO LED Duo can also help support under-eye rejuvenation.

Most people notice smoother texture and increased brightness within 1–2 weeks. More visible improvements—such as enhanced tone, clarity, and reduction in fine lines—typically develop over 4–6 weeks with consistent use. Daily SPF and proper hydration will help optimize results.